Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
24-1/2
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
24-1/2
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #56710
advertisement
Xie X
17
Showing records 1 to 17 |
Display all abstracts from
Xie X
110050
Inducible -CreER Mouse Line for Studying Gene Function in Retinal Ganglion Cell Physiology and Disease
Guo L
Cells
2023; 12:
109941
24-Hour efficacy of single primary selective laser trabeculoplasty versus latanoprost eye drops for Naïve primary open-angle glaucoma and ocular hypertension patients
Shi Y; Zhang Y
Scientific reports
2023; 13: 12179
110050
Inducible -CreER Mouse Line for Studying Gene Function in Retinal Ganglion Cell Physiology and Disease
Xie X
Cells
2023; 12:
109941
24-Hour efficacy of single primary selective laser trabeculoplasty versus latanoprost eye drops for Naïve primary open-angle glaucoma and ocular hypertension patients
Sun W
Scientific reports
2023; 13: 12179
110050
Inducible -CreER Mouse Line for Studying Gene Function in Retinal Ganglion Cell Physiology and Disease
Wang J
Cells
2023; 12:
109941
24-Hour efficacy of single primary selective laser trabeculoplasty versus latanoprost eye drops for Naïve primary open-angle glaucoma and ocular hypertension patients
Huang AS
Scientific reports
2023; 13: 12179
110050
Inducible -CreER Mouse Line for Studying Gene Function in Retinal Ganglion Cell Physiology and Disease
Xiao H; Li S
Cells
2023; 12:
109941
24-Hour efficacy of single primary selective laser trabeculoplasty versus latanoprost eye drops for Naïve primary open-angle glaucoma and ocular hypertension patients
Chen S
Scientific reports
2023; 13: 12179
110050
Inducible -CreER Mouse Line for Studying Gene Function in Retinal Ganglion Cell Physiology and Disease
Xu M
Cells
2023; 12:
109941
24-Hour efficacy of single primary selective laser trabeculoplasty versus latanoprost eye drops for Naïve primary open-angle glaucoma and ocular hypertension patients
Zhang L
Scientific reports
2023; 13: 12179
110050
Inducible -CreER Mouse Line for Studying Gene Function in Retinal Ganglion Cell Physiology and Disease
Quainoo E
Cells
2023; 12:
109941
24-Hour efficacy of single primary selective laser trabeculoplasty versus latanoprost eye drops for Naïve primary open-angle glaucoma and ocular hypertension patients
Wang W
Scientific reports
2023; 13: 12179
110050
Inducible -CreER Mouse Line for Studying Gene Function in Retinal Ganglion Cell Physiology and Disease
Koppaka R
Cells
2023; 12:
109941
24-Hour efficacy of single primary selective laser trabeculoplasty versus latanoprost eye drops for Naïve primary open-angle glaucoma and ocular hypertension patients
Xie L
Scientific reports
2023; 13: 12179
110050
Inducible -CreER Mouse Line for Studying Gene Function in Retinal Ganglion Cell Physiology and Disease
Zhuo J
Cells
2023; 12:
109941
24-Hour efficacy of single primary selective laser trabeculoplasty versus latanoprost eye drops for Naïve primary open-angle glaucoma and ocular hypertension patients
Xie X
Scientific reports
2023; 13: 12179
110050
Inducible -CreER Mouse Line for Studying Gene Function in Retinal Ganglion Cell Physiology and Disease
Smith SB; Gan L
Cells
2023; 12:
Issue
24-1/2
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept